McKesson Corporation (NYSE:MCK) Receives Consensus Recommendation of “Moderate Buy” from Analysts

McKesson Corporation (NYSE:MCK) has been given a consensus rating of “Moderate Buy” by the seventeen ratings firms that are currently covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $960.9333.

Several research firms recently issued reports on MCK. Leerink Partners reiterated an “outperform” rating and issued a $1,085.00 price objective on shares of McKesson in a report on Thursday, March 5th. Mizuho raised their target price on McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. TD Cowen boosted their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Wells Fargo & Company increased their price target on shares of McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th.

McKesson Price Performance

NYSE MCK opened at $888.28 on Friday. The stock has a market capitalization of $108.81 billion, a P/E ratio of 25.55, a PEG ratio of 1.43 and a beta of 0.38. The firm’s 50-day moving average is $903.68 and its two-hundred day moving average is $833.49. McKesson has a 12 month low of $637.00 and a 12 month high of $999.00.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the previous year, the firm earned $8.03 EPS. The business’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, analysts anticipate that McKesson will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio is 9.43%.

Insiders Place Their Bets

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of McKesson stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the transaction, the executive vice president owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 3,868 shares of company stock valued at $3,743,820. Corporate insiders own 0.08% of the company’s stock.

Institutional Investors Weigh In On McKesson

A number of hedge funds have recently bought and sold shares of the stock. University of Texas Texas AM Investment Management Co. purchased a new stake in shares of McKesson during the fourth quarter worth approximately $25,000. Swiss RE Ltd. purchased a new stake in shares of McKesson in the 4th quarter valued at approximately $26,000. GGM Financials LLC purchased a new stake in shares of McKesson in the 3rd quarter valued at approximately $25,000. State of Wyoming acquired a new stake in shares of McKesson in the 2nd quarter valued at $29,000. Finally, Hopwood Financial Services Inc. purchased a new stake in shares of McKesson during the 3rd quarter worth $31,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.